Source:http://linkedlifedata.com/resource/pubmed/id/21434863
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2011-4-12
|
pubmed:abstractText |
Hepatic fatty acid (FA) composition, especially a reduction in n-3 polyunsaturated FA (PUFA) may contribute to the pathogenesis of non-alcoholic fatty liver disease (NAFLD), which is common in HIV-infection.. In a cross-sectional study we compared hepatic FA composition between 20 HIV-infected men with NAFLD (HIV/NAFLD), 21 HIV-negative men with NAFLD (NAFLD), and 7 healthy controls. Within HIV/NAFLD we compared simple steatosis (HIV/SS) to steatohepatitis (HIV/NASH). FA composition in liver and erythrocytes, oxidative stress, diet, and exercise were assessed. Major findings (P<0.05) were: 1) higher hepatic n-6/n-3 ratio in HIV/NAFLD [median (range)] [8.08 (1.08-21.52)] compared to controls [5.83 (3.58-6.93)] and NAFLD [5.97 (1.46-10.40)], with higher n-6 PUFA in HIV/NAFLD compared to NAFLD; 2) lower n-3 PUFA in erythrocytes (mol%), a marker for dietary intake, in HIV/NAFLD [5.26 (1.04-11.75)] compared to controls [8.92 (4.79-12.67)]; 3) the ratios of long-chain PUFA products to essential FA precursors of the n-6 and n-3 series were lower in HIV/NAFLD and NAFLD compared to controls. In contrast, the ratio of oleic/stearic acid was higher in HIV/NAFLD compared to the other groups. These ratios are indirect markers of enzymatic FA desaturation and elongation. Hepatic PUFA, especially biologically active long-chain PUFA, were also lower in HIV/NASH compared to HIV/SS. Oxidative stress was not different among the groups. We conclude that HIV/NAFLD is associated with altered hepatic FA composition. Changes may be due to impaired FA metabolism or suboptimal n-3 PUFA intake. The potential role of n-3 PUFA (e.g. fish oil) to treat or prevent HIV/NAFLD warrants further investigation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1873-4251
|
pubmed:author |
pubmed-author:AghdassiElahehE,
pubmed-author:AllardJohane PJP,
pubmed-author:ArendtBianca MBM,
pubmed-author:GuindiMahaM,
pubmed-author:HeathcoteE JennyEJ,
pubmed-author:MaDavid W LDW,
pubmed-author:MohammedSaira SSS,
pubmed-author:SalitIrving EIE,
pubmed-author:ShermanMorrisM,
pubmed-author:WongDavid K HDK
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
128-35
|
pubmed:meshHeading |
pubmed-meshheading:21434863-Adolescent,
pubmed-meshheading:21434863-Adult,
pubmed-meshheading:21434863-Aged,
pubmed-meshheading:21434863-Cross-Sectional Studies,
pubmed-meshheading:21434863-Diet,
pubmed-meshheading:21434863-Erythrocytes,
pubmed-meshheading:21434863-Fatty Acids,
pubmed-meshheading:21434863-Fatty Liver,
pubmed-meshheading:21434863-HIV Infections,
pubmed-meshheading:21434863-Humans,
pubmed-meshheading:21434863-Liver,
pubmed-meshheading:21434863-Male,
pubmed-meshheading:21434863-Middle Aged,
pubmed-meshheading:21434863-Motor Activity,
pubmed-meshheading:21434863-Oxidative Stress,
pubmed-meshheading:21434863-Young Adult
|
pubmed:year |
2011
|
pubmed:articleTitle |
Non-alcoholic fatty liver disease in HIV infection associated with altered hepatic fatty acid composition.
|
pubmed:affiliation |
University Health Network, Dept. of Medicine, Toronto, Ontario, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|